Cybrexa President & CEO
Per Hellsund is currently the co-founder, President, and CEO of Cybrexa, a start-up focused on developing an entirely new class of small molecule DNA repair inhibitors that directly target the tumor microenvironment. Previously, he was Co-founder, President & CEO of CyVek, where in just over four years he led the development, commercialization and exit of a novel automated immunoassay system that was acquired by Bio-techne. Before that, he was the president of inc.jet, Inc., a start-up in the inkjet printing space that led the introduction of thermal inkjet printing into the commercial printing space. Hellsund has undergraduate degrees in Mechanical Engineering and Business, and a Master’s Degree in Management from the Rensselaer Polytechnic Institute.
5 Science Park 395 Winchester Ave. New Haven, CT 06511 (860) 717-2731